SCHEMBL4098725

SCHEMBL4098725

CCCCCC=CCC=CCC=CCC=CCCCC(=O)Oc1ccc(C=Cc2cc(OC(=O)CCCC=CCC=CCC=CCC=CCCCCC)cc(OC(=O)CCCC=CCC=CCC=CCC=CCCCCC)c2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.50
KMT2A Q03164 3/20 0.50
KDM4E B2RXH2 2/20 0.50
MEN1 O00255 2/20 0.50
LMNA P02545 2/20 0.50
TP53 P04637 2/20 0.50
CYP3A4 P08684 2/20 0.50
TTR P02766 1/20 0.50
SMN1; SMN2 Q16637 1/20 0.50
MGLL Q99685 1/20 0.48
CNR1 P21554 6/20 0.47
CNR2 P34972 4/20 0.47
ALDH1A1 P00352 3/20 0.47
FAAH O00519 3/20 0.47
HPGD P15428 2/20 0.47
THRB P10828 1/20 0.47
PPARG P37231 2/20 0.46
USP2 O75604 1/20 0.46
HSPD1 P10809 1/20 0.46
CYP19A1 P11511 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2523313 0.96 KDM4E (0.49) MAPTKMT2AKDM4EMEN1LMNA
SCHEMBL4097199 0.94 MGLL (0.45) MAPTKMT2AKDM4EMEN1LMNA
SCHEMBL4099328 0.94 KMT2A (0.51) MAPTKMT2AKDM4EMEN1LMNA
SCHEMBL2519160 0.94 KMT2A (0.51) MAPTKMT2AKDM4EMEN1LMNA
SCHEMBL4096611 0.93 MAPT (0.51) MAPTKMT2AKDM4EMEN1LMNA
SCHEMBL4103844 0.92 MGLL (0.47) MAPTKMT2AKDM4EMEN1LMNA
SCHEMBL2515292 0.91 ALB (0.45) MAPTKMT2AKDM4EMEN1LMNA
SCHEMBL2518028 0.90 PSMB11 (0.48) MAPTKMT2AKDM4EMEN1LMNA
SCHEMBL4099862 0.90 CNR1 (0.50) MAPTKMT2AKDM4EMEN1LMNA
SCHEMBL2517222 0.89 ALDH1A1 (0.55) MAPTKMT2AKDM4EMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9295621-B2 Emulsion cosmetic compositions containing resveratrol derivatives and silicone surfactant ELC MANAGEMENT LLC (US) 2016-03-29 US disclosed
US-20090035240-A1 Aqueous Based Cosmetic Compositions Containing Resveratrol Derivatives And An Aqueous Phase Structuring Agent ELC MANAGEMENT LLC 2009-02-05 US disclosed
US-20090035237-A1 Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And Silicone Surfactant ELC MANAGEMENT LLC 2009-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090035237-A1 Emulsion Cosmetic Compositions Containing Resveratrol Derivatives And Silicone Surfactant SMURF1, CUTA, SMURF2 MAPT 2543/4885KMT2A 1425/4885KDM4E 1074/4885
US-20090035240-A1 Aqueous Based Cosmetic Compositions Containing Resveratrol Derivatives And An Aqueous Phase Structuring Agent SMARCC1, RARG, RARA MAPT 899/4885KMT2A 1387/4885KDM4E 2286/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.